0001305773-22-000037.txt : 20220323 0001305773-22-000037.hdr.sgml : 20220323 20220323162209 ACCESSION NUMBER: 0001305773-22-000037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220314 FILED AS OF DATE: 20220323 DATE AS OF CHANGE: 20220323 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pedulla Denise E CENTRAL INDEX KEY: 0001804602 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37474 FILM NUMBER: 22763469 MAIL ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Conformis Inc CENTRAL INDEX KEY: 0001305773 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 600 TECHNOLOGY DRIVE CITY: BILLERICA STATE: MA ZIP: 01821 BUSINESS PHONE: (781) 345-9001 MAIL ADDRESS: STREET 1: 600 TECHNOLOGY DRIVE CITY: BILLERICA STATE: MA ZIP: 01821 FORMER COMPANY: FORMER CONFORMED NAME: ConforMIS Inc DATE OF NAME CHANGE: 20041013 4 1 wf-form4_164806691657223.xml FORM 4 X0306 4 2022-03-14 0 0001305773 Conformis Inc CFMS 0001804602 Pedulla Denise E C/O CONFORMIS INC 600 TECHNOLOGY PARK DRIVE BILLERICA MA 01821 0 1 0 0 CLO & SECRETARY Common Stock 2022-03-14 4 A 0 450000 0 A 450000 D Stock Option (right to buy) 0.61 2022-03-14 4 A 0 450000 0 A 2023-03-14 2032-03-14 Common Stock 450000.0 450000 D Represents an inducement grant award of restricted stock units to the Reporting Person in connection with her appointment as CLO and Secretary. The restricted stock units vest over eight years, with the following schedule: 8%, 10%, 15%, 20%, 20%, 15%, 8% and 4% of the total number of shares vesting on each one-year anniversary of the grant date, subject to the Reporting Person's continued service as an employee of Conformis through the applicable vesting dates, and are subject to certain forfeiture provisions. Represents an inducement grant award of options to the Reporting Person in connection with her appointment as CLO and Secretary. The option to purchase an aggregate of 450,000 shares of Issuer's common stock vests over eight years, with the following schedule: 8%, 10%, 15%, 20%, 20%, 15%, 8% and 4% of the total number of shares underlying the option vesting on each one-year anniversary of the grant date, subject to the Reporting Person's continued service as an employee of Conformis through the applicable vesting dates, and are subject to the certain forfeiture provisions. Denise E. Pedulla 2022-03-23